Penumbra, Inc. Common Stock

Financials

İşletme faaliyetlerinden elde edilen nakit -33.24 M9.5 M-55.66 M97.33 M168.48 M238.66 M 276.66 M Yatırım faaliyetlerinden elde edilen nakit -104.15 M-21.73 M54.79 M-16.08 M77.62 M-404.59 M -434.72 M Finansman faaliyetlerinden elde edilen nakit 134.92 M836 K11.62 M16.2 M-87.01 M26.53 M 21.92 M Serbest nakit akışı -33.24 M9.5 M-55.66 M97.33 M168.48 M174.93 M 212.73 M

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by yearend.

PEN

Financials

Penumbra, Inc. Common Stock

Haberler

Baron Health Care Fund Q1 2026 Portfolio Activity

Penumbra hissesi 328,69 dolarla 52 haftalık zirve yaptı

Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades

Penumbra hissedarları Boston Scientific ile birleşmeyi onayladı

Penumbra (PEN) Misses Q1 Earnings Estimates

ALC vs. PEN: Which Stock Should Value Investors Buy Now?

NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry

3 Reasons Why Penumbra (PEN) Is a Great Growth Stock

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

Here's Why Penumbra (PEN) is a Strong Growth Stock

Penumbra çalışması pulmoner emboli için iyileşme gösterdi

3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)